From May 1993 to Oct. 1994, 1~3courses of 2×10~9~3×10~9 TAK cells wereinfused for 2 patients with stage Ⅲ renal cellcarcinoma and 15 with stage Ⅳ (Robson’sstage). Complete response has been noted in 1and partial response in 3. The total responserate has been 23.5% and increased by 37.5%when radical nephrectomy and adoptive TAKcells were used together. Up to Feb. 1995, the